FSTL1 confers the invasive potential and bone tropism on tumor cells, and also generates and expands CD45−ALCAM+ MSCs initially in bone marrow and sequentially all over the body in the host (Kudo-Saito, 2013; Kudo-Saito et al., 2013a). The gene discussed is FSTL1; the disease is neoplasm.